Company IRIDEX Corporation

Equities

IRIX

US4626841013

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 02:00:01 04/05/2024 am IST 5-day change 1st Jan Change
2.8 USD -1.74% Intraday chart for IRIDEX Corporation -2.44% -0.36%

Business Summary

IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Number of employees: 111

Sales per Business

USD in Million2022Weight2023Weight Delta
Retina
56.8 %
32 55.6 % 29 56.8 % -6.99%
Cyclo G6
26.0 %
15 25.8 % 13 26.0 % -8.39%
Other
17.3 %
11 18.6 % 9 17.3 % -15.61%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
50.2 %
29 51.2 % 26 50.2 % -10.71%
Europe, Middle East and Africa
26.1 %
14 24.2 % 14 26.1 % -2.04%
Asia/Pacific Rim
19.7 %
11 19.2 % 10 19.7 % -6.38%
Americas, excluding the United States
4.0 %
3 5.4 % 2 4.0 % -32.64%

Managers

Managers TitleAgeSince
Chief Executive Officer 64 13/18/13
Director of Finance/CFO 54 11/20/11
Chief Operating Officer 52 01/18/01
Investor Relations Contact - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 64 17/22/17
Director/Board Member 70 02/19/02
Director/Board Member 75 15/18/15
Chairman 58 23/19/23
Chief Executive Officer 64 13/18/13
Director/Board Member 50 01/21/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,252,948 12,234,154 ( 75.27 %) 0 75.27 %

Shareholders

NameEquities%Valuation
1,612,122 9.922 % 5 M $
Stanley Manne Trust
6.599 %
1,072,215 6.599 % 3 M $
Paragon Associates
6.155 %
1,000,000 6.155 % 3 M $
881,998 5.428 % 3 M $
Vanguard Global Advisers LLC
3.429 %
557,199 3.429 % 2 M $
Renaissance Technologies LLC
2.555 %
415,060 2.555 % 1 M $
AMH Equity Ltd.
2.437 %
396,000 2.437 % 1 M $
160,103 0.9854 % 477 107 $
Geode Capital Management LLC
0.7428 %
120,694 0.7428 % 359 668 $
ARS Investment Partners LLC
0.6774 %
110,065 0.6774 % 327 994 $

Company contact information

IRIDEX Corp.

1212 Terra Bella Avenue

94043, Mountain View

+

http://www.iridex.com
address IRIDEX Corporation(IRIX)
  1. Stock Market
  2. Equities
  3. IRIX Stock
  4. Company IRIDEX Corporation